Login

Financial Snapshot

Revenue
Last 4 Quarters
N/A
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
$234.5K
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
357.55%
Total Assets
2026 Q1
Total Liabilities
Last 4 Quarters
N/A
Book Value
Last 4 Quarters
N/A
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap:

About

AEI Income & Growth Fund XXII Limited Partnership (XAEIU) is a real estate limited partnership that acquires and leases single-tenant commercial properties in the United States under net lease arrangements. Revenue comes from base annual rental payments, made in monthly installments, with contractual rent increases over the lease term. The Partnership was organized under Minnesota law on July 31, 1996, commenced operations May 1, 1997, and received total subscriptions of $16,917,222 from 16,917.222 Limited Partnership Units sold at $1,000 per Unit. From those proceeds, the Partnership purchased twelve properties, including partial interests in three, at a total cost of $13,363,547. As of December 31, 2025, there were 529 holders of record of Limited Partnership Units. The Managing General Partner, AEI Fund Management XXI, Inc., has initiated the final liquidation process. As of December 31, 2025, the Partnership held interests in properties including a Talecris Plasma Facility in Dallas, Texas and a DaVita Dialysis facility in Hempstead, Texas.

Revenue model
Base annual rental income collected in monthly installments from tenants under long-term net leases, with contractual rent escalations. Tenants bear responsibility for real estate taxes, insurance, maintenance, repairs, and operating expenses. Quarterly distributions are made to General Partners and Limited Partners from net cash flow, totaling $1,282,247 declared in 2025 and $276,879 declared in 2024 (per 10-K filed 2026-03-27).
Products and services
Ownership and net leasing of single-tenant commercial real estate properties in the United States. Properties include the Talecris Plasma Facility in Dallas, Texas and a DaVita Dialysis facility in Hempstead, Texas, as of December 31, 2025. Leases carry primary terms with two to five five-year renewal options.
Customers and end markets
Single-tenant commercial property lessees. Named tenants include Talecris Plasma Resources, Inc. (plasma collection facility, Dallas, Texas) and Bollinger Dialysis, LLC operating a DaVita Dialysis facility (Hempstead, Texas), as of December 31, 2025.
Value-chain role
Passive net lease landlord. The Partnership acquires properties, leases them to tenants on long-term net leases, collects rent, and distributes cash flow to partners. The Managing General Partner, AEI Fund Management XXI, Inc., handles property management and partnership administration.
Geographic exposure
United States only. Named properties located in Texas (Dallas and Hempstead), per 10-K filed 2026-03-27.

Source: SEC 10-K, filed 2026-03-27

Industry: Real Estate

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support